CD8A and neoplasm: With the addition of 10 μg/mL Met, the CD44 + CD62L + population of effector CD8+ T cells (CD8+ Teff) increased by 7.45% and the PD-1 expression was down-regulated, suggesting that Met might have potential anti-tumor activity (Fig. 2D, E).